'I’m a Neuroscientist, and This 10-Second Habit Can Instantly Boost Your Focus' originally appeared on Parade.

A study found no rise in ADHD cases, though some drugs for the disorder are still in shortage amid high demand.

Topline data were announced from a phase 3 trial evaluating CTx-1301 for the treatment of pediatric patients aged 6 to 17 years with ADHD.

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced ...

Koraput: Health and Family Welfare Minister Mukesh Mahaling on Thursday directed the fact-finding team, probing the death of ...

DelveInsight's Major Depressive Disorder pipeline report depicts a robust space with 75+ active players working to develop ...

In response to the FDA's feedback, Axsome plans to conduct an additional controlled trial that will use a fixed-dose paradigm ...

Narcolepsy disrupts more than sleep—it affects daily life. Learn about causes, symptoms, diagnosis, and the latest treatment ...

AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor for the management of fibromyalgia and other conditions. Esreboxetine, the SS-enantiomer of reboxetine, is more ...

A Science-Backed Look at Java Burn's Weight Loss Claims, Ingredient Mechanisms, Real Customer Results, and Whether This Viral ...

Discover How Science Natural Supplements Saffron Enhances Emotional Well-Being With 88.5mg Extract & Triple-Compound Synergy ...

If you’re a (theatrical) adrenaline junkie, then you need to choose a streaming service that has an extensive library of action movies. Watch With Us recommends you check out Amazon Prime Video.